Targeting SCD1 in KRAS Mutant Non-Small Cell Lung Cancer: A Novel Therapeutic Strategy
Uncover the impact of SCD1 in NSCLC with concurrent KRAS, STK11, and KEAP1 mutations. Learn about the potential of SCD1 as a novel therapeutic target for overcoming treatment resistance in lung cancer.